Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS5627870 A
Publication typeGrant
Application numberUS 08/381,858
Publication dateMay 6, 1997
Filing dateJun 6, 1994
Priority dateJun 7, 1993
Fee statusLapsed
Also published asCA2141798A1, DE69406898D1, DE69406898T2, EP0655008A1, EP0655008B1, WO1994028973A1
Publication number08381858, 381858, US 5627870 A, US 5627870A, US-A-5627870, US5627870 A, US5627870A
InventorsBernard Kopecky
Original AssigneeAtea, Societe Atlantique De Techniques Avancees
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Device for treating cerebral lesions by gamma radiation, and corresponding treatment apparatus
US 5627870 A
Abstract
A device for treating cerebral lesions by gamma radiation, comprising an approximately semi-spherical source-collimator assembly having a large number of gamma ray sources associated with channels directed to the same focal point. Each gamma ray source is associated with a group of channels arranged in the manner of a cone, the apex of which is at the focal point.
Images(3)
Previous page
Next page
Claims(6)
I claim:
1. Device for treating cerebral lesions by gamma radiation, of the type comprising an approximately hemispherical source/collimator assembly (2) which includes a large number of gamma-ray sources (21) associated with channels (20) which are all oriented towards one and the same focusing point (18), characterized in that each gamma-ray source (21) is associated with a bundle (17) of channels (20) bounded by a conical envelope of revolution (19), the vertex of which is located at the focusing point (18).
2. Device according to claim 1, wherein each source (21) lies opposite the entrance opening of all the channels (20) of the bundle (17) which is associated with it.
3. Device according to claim 1 wherein all the channels (20) are cylindrical.
4. Device according to claim 1 wherein all the channels (20) have substantially the same dimensions.
5. Device according to claim 1, wherein each bundle (17) includes at least five channels (20).
6. Apparatus for treating cerebral lesions by gamma radiation, comprising a device according to claim 1, and a movable patient-supporting table (4) equipped with a stereotactic device (26) intended to interact with the patient's head.
Description
FIELD OF THE INVENTION

The present invention relates to a device for treating cerebral lesions by gamma radiation, of the type comprising an approximately hemispherical source/collimator assembly which includes a large number of gamma-ray sources associated with channels which are all oriented towards one and the same focusing point.

BACKGROUND OF THE INVENTION

Gamma-radiation apparatuses have been proposed for non-invasive neurosurgery of the brain in order to treat cerebral lesions without opening the cranium. Destruction of the lesions is achieved by precisely concentrating gamma radiation onto the areas to be treated, such as venous malformations or tumors. These apparatuses are often designated by the name "gamma surgical apparatuses" or "gamma bistouries".

In these apparatuses, external gamma-radiation sources are used, the radiation being directed and concentrated, in a precise manner, onto the treated lesion in order for the desired dose to be absorbed by this lesion without appreciably damaging the intermediate tissues intervening between the sources and the lesion, nor the tissues surrounding the lesion and, in a general manner, reducing to a minimum the radiation doses absorbed by the healthy tissues.

This is achieved especially by the devices of the aforementioned type, an example of which is described in FR-A-2,672,220. In this technology, a large number of fixed external sources are used, these being collimated individually and arranged radially so that the axes of the rays that they produce converge onto a focal point which coincides with the lesion to be treated. The intensity of each beam is insufficient to damage the intermediate healthy tissues through which it passes, especially as the device is given, during the treatment, an angular movement about the focusing point. In contrast, at the point of convergence or focal point, the dose received by the lesion is sufficient to destroy it.

In this known technique, each source is associated with an at least approximately conical single channel, the generatrices of which converge towards the focusing point and in which a conical central needle made of a material absorbing the gamma rays is positioned.

SUMMARY OF THE INVENTION

The object of the invention is to improve this known device so as better to concentrate the radiation at the focusing point in order to improve the effectiveness of the treatment, while at the same time better protecting the healthy areas in the brain from the gamma radiation.

For this purpose, the invention is a treatment device of the aforementioned type, in which each gamma-ray source is associated with a bundle of channels bounded by a conical envelope of revolution, the vertex of which is located at the focusing point.

The device may include one or more of the following characteristics:

each source lies opposite the entrance opening of all the channels of the bundle which is associated with it;

all the channels are cylindrical;

all the channels have substantially the same dimensions;

each bundle includes at least five channels.

The invention also relates to an apparatus for treating cerebral lesions by gamma radiation, comprising a device such as defined hereinabove, and a movable patient-supporting table equipped with a stereotactic device intended to interact with the patient's head.

BRIEF DESCRIPTION OF THE DRAWINGS

An illustrative embodiment of the invention will now be described with reference to the appended drawings, in which:

FIG. 1 is a schematic overall view, in side elevation and partly in section, of a treatment apparatus in accordance with the invention, in the stand-by position;

FIG. 2 depicts, in a similar manner, the apparatus during treatment;

FIG. 3 is a side-on view of the source/collimator assembly indicating the possible positions of the patient's head;

FIG. 4 is a front view of the subject of FIG. 3;

FIG. 5 depicts, in longitudinal section and on a larger scale, the region of the source/collimator assembly associated with a source;

FIG. 6 illustrates, in perspective, the set of channels associated with a source;

FIG. 7 is a view taken in the direction of FIG. 5; and

FIG. 8 illustrates, by means of a diagram, the energy-flux distribution in the vicinity of the focusing point.

DETAILED DESCRIPTION

The apparatus for treating cerebral lesions, depicted in FIGS. 1 and 2, is of the type described in the aforementioned FR-A-2,672,220. It comprises a fixed main frame 1 in the upper part of which a source/collimator assembly 2 is mounted. Attached to this frame is a fixed secondary frame 3 which supports a patient-supporting table 4, this being achieved by means of a numerical-control motorized device 5 which enables the table to be moved parallel to itself in three orthogonal directions, X (which is the longitudinal direction of the table), Y and Z (vertical direction). The frames 1 and 3 contain, moreover, appropriate electronic calculating means for the control, these being shown schematically at 6A and 6B, respectively, in order to provide the operation which will be described hereinbelow.

The source/collimator assembly 2, which may be seen better in FIGS. 3 and 4, has a substantially hemispherical general shape. It comprises a thick external shield 7, made of pure or low-alloy lead, the external surface of which matches, with a small radial clearance, the internal surface of a shell 8 of the frame 1. This shell is closed on all sides, with the exception of a front opening 9 just sufficient to allow passage of the table 4 supporting a patient.

Positioned in the shield 7 are, a thin source-holder 10 and, on the inside of the latter, a thick collimator 11 defining a spherical internal surface 12. The members 10 and 11 are fixed in the shield by means of a peripheral ring 13 which is itself held by a crimped annular flange 14.

Passing right through the central region of assembly 2, shown in the side-on view (FIG. 3) and over a greater angular extent in the front view (FIG. 4), is a large number of groups of radial channels. Each group consists of a stepped outer channel 15 passing through the shield, of a cylindrical channel 16 passing through the source holder and of a bundle of channels 17 passing through the collimator. The axes of all these channels converge towards a focusing point 18, which is the center of the sphere.

As depicted in FIGS. 5 to 7, each bundle 17 is bounded by an imaginary cone-shaped envelope 19, the vertex of which is located at the point 18. The large base and the small base of the envelope 19, in the region of the external and internal surfaces of the collimator 11, have, respective, diameters of the order of 20 mm and 10 mm. The bundle 17 consists of a certain number of fine cylindrical channels 20, all the axes of which converge towards the point 18. The diameter of each channel 20 is of the order of 2 to 3 mm and the number of channels in one bundle depends on the space available in the envelope 19. This number is, for example, five or more, as illustrated in FIG. 7.

The bulk of the collimator 11 consists of a highly gamma-ray absorbent material, especially pure or low-alloy lead or natural uranium or uranium depleted of isotope 235, rendered non-oxidizable by disposition of a protective layer or by alloying, especially on the wall of each channel 20.

A caesium 137 gamma-ray source, of cylindrical shape, the diameter of which is approximately equal to the large diameter of the envelope 19, is arranged in the channel 16 and held in place therein by a pressing member 22 inserted into and appropriately fixed in the channel 15 (FIGS. 3 and 4).

A port 23 is mounted so as to tilt on the frame 1 about a horizontal and transverse spindle 24 and carries a block 25 consisting of a highly gamma-ray absorbent material, for example uranium.

The table 4 carries a stereotactic device 26 supported by uprights 27 fixed to the table.

The operation of the apparatus will now be described.

A preliminary investigation phase has allowed the patient's head to be positioned in the stereotactic 26 device and the lesion to be treated to be identified in space.

For the treatment, the table 4 being removed from the frame 1 (FIG. 1), the patient's head is firstly repositioned in the same manner. The port 23 is then closed and is applied to the perimeter of the ring 13, and the block 25 lies at the focusing point 18 and absorbs the focused gamma rays.

Next, the port 23 is opened and the patient's head is inserted under the collimator via the opening 9, the table being made to carry out a first approach movement in directions X and Z and then a final adjustment movement in directions X and Y of the order of 70 mm (reference D in FIGS. 3 and 4). This brings the lesion, identified by means of the device 26, into coincidence with the point 18. The head then lies at an appreciable radial distance from the internal surface 12 of the assembly 2, which distance is very much greater than the dimensions of the lesion to be treated.

Then, during the treatment, the contour of the lesion is followed by means of small movements of the table in directions X, Y and Z, of the order of 10 mm, called treatment movements (reference d in FIGS. 3 and 4). Simultaneously, the collimator is given an oscillatory movement, with a small angle a of approximately 5, about the aforementioned spindle which passes through the gamma-ray focusing point (FIG. 3).

The three-dimensional movement of the table 4 is very precise, of the type used in certain numerical-control machine tools. It is controlled by a computer, on the basis of medical-imaging data obtained using a scanner, magnetic resonance or other techniques. It enables, from just the one initial adjustment, arbitrarily shaped lesions to be treated very accurately in a single operation.

The oscillatory movement of the assembly 2 enables the healthy tissues, located between it and the focusing point, not to be damaged, and it also enables any contact of particularly sensitive areas in the brain with the gamma rays to be avoided.

Moreover, each surface element of the source, located opposite a channel, emits radiation which will either be absorbed by the wall of this channel or will pass to the point 18 or very close to it. In particular, in a plane perpendicular to the central axis of the envelope 20, the entire beam is concentrated onto a very small length AB (FIGS. 5 and 6). In addition, as depicted in FIG. 8, where the cumulative energy E of the gamma rays is plotted as ordinates and the distance d from the point 18 as abscissae, virtually the entire energy of the gamma rays is concentrated in the region which immediately surrounds the focal point 18, forming an almost rectangular pulse, the energy being virtually zero at the points A and B. In other words, a relatively narrow focal spot is obtained, which spot typically has a diameter of the order of a few mm, especially 2 to 4 mm, and in which virtually all the gamma energy is concentrated.

Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US4780898 *Apr 30, 1987Oct 25, 1988Elekta InstrumentArrangement in a gamma unit
US5528653 *Apr 8, 1994Jun 18, 1996Song; ShipengRotational coniformly-focused gamma radiating unit
EP0248774A1 *Apr 15, 1987Dec 9, 1987Elekta Instrument S.A.Arrangement in a gamma unit
EP0371303A1 *Nov 11, 1989Jun 6, 1990Varian International AG.Radiation therapy apparatus
EP0431785A1 *Nov 19, 1990Jun 12, 1991Mark P. CarolStereotactic-guided radiation therapy system
FR2672220A1 * Title not available
Non-Patent Citations
Reference
1 *Search Report FR 93 06787 1994.
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US6044126 *Jun 22, 1998Mar 28, 2000Ch&U De LilleProcess for automatically determining the configuration of a stereotactic radiosurgery helmet to which can be fitted a plurality of collimators focused on an irradiation isocenter
US6259762Aug 19, 1998Jul 10, 2001Deutsches Krebsforschungszentrum Stiftung Des Offentlichen RechtsRadiation system with several radiation sources directed to a control point
US6377846 *Feb 21, 1997Apr 23, 2002Medtronic Ave, Inc.Device for delivering localized x-ray radiation and method of manufacture
US6512813May 2, 2000Jan 28, 2003Franz KrispelRotating stereotactic treatment system
US6918922Jan 28, 2003Jul 19, 2005Amir OronIschemia laser treatment
US6931096 *Jun 30, 2003Aug 16, 2005Elekta AbRadiation therapy device
US7303578Oct 9, 2003Dec 4, 2007Photothera, Inc.Device and method for providing phototherapy to the brain
US7309348Jan 19, 2005Dec 18, 2007Photothera, Inc.Method for treatment of depression
US7316922Jan 8, 2003Jan 8, 2008Photothera Inc.Method for preserving organs for transplant
US7534255Jan 26, 2004May 19, 2009Photothera, IncLow level light therapy for enhancement of neurologic function
US7575589Mar 21, 2006Aug 18, 2009Photothera, Inc.Light-emitting device and method for providing phototherapy to the brain
US7659530 *Jul 31, 2007Feb 9, 2010Yanxiong QiuFocusing and shielding device for encephalic photon knife
US7695504Jan 7, 2008Apr 13, 2010The United States Of America As Represented By The Department Of Health And Human ServicesMethod for regeneration and functional recovery after spinal cord injury using phototherapy
US7729473 *Jul 29, 2008Jun 1, 2010Elekta Ab (Publ)Image-guided multi-source radiotherapy
US7835492Nov 27, 2007Nov 16, 2010Velayudhan SahadevanLethal and sublethal damage repair inhibiting image guided simultaneous all field divergent and pencil beam photon and electron radiation therapy and radiosurgery
US7848035Sep 18, 2008Dec 7, 2010Photothera, Inc.Single-use lens assembly
US8025687May 4, 2009Sep 27, 2011Photothera, Inc.Low level light therapy for enhancement of neurologic function
US8139714Jun 25, 2009Mar 20, 2012Velayudhan SahadevanFew seconds beam on time, breathing synchronized image guided all fields simultaneous radiation therapy combined with hyperthermia
US8149526Nov 2, 2010Apr 3, 2012Photothera, Inc.Single use lens assembly
US8167921Jun 20, 2011May 1, 2012Jackson StreeterLow level light therapy for enhancement of neurologic function
US8308784Aug 23, 2007Nov 13, 2012Jackson StreeterLow level light therapy for enhancement of neurologic function of a patient affected by Parkinson's disease
US8328857Feb 25, 2010Dec 11, 2012The United States Of America As Represented By The Department Of Health And Human ServicesMethod for treating a patient having a spinal cord injury using phototherapy
US20130240761 *Aug 16, 2011Sep 19, 2013Shipeng SongSelf-focusing radioactive source device and radiating apparatus employing the same
CN100512906CDec 31, 2003Jul 15, 2009深圳市尊瑞科技有限公司Collimation aperture variable collimation device and varying method thereof
CN100540088CDec 31, 2003Sep 16, 2009深圳市尊瑞科技有限公司Radiation device for radiation therapy and radiation method therefor
CN100546670CApr 18, 2003Oct 7, 2009伽玛星医疗工业(上海)有限公司Gamma-ray therapeutic apparatus
CN100563751CJan 4, 2007Dec 2, 2009吕风华;李 萍Gamma ray focusing radiation unit
DE19736192A1 *Aug 20, 1997Mar 4, 1999Deutsches KrebsforschBestrahlungsanlage mit mehreren auf ein Zentrum ausgerichteten Strahlenquellen
DE19736192C2 *Aug 20, 1997Jul 1, 1999Deutsches KrebsforschBestrahlungsanlage mit mehreren auf ein Zentrum ausgerichteten Strahlenquellen
WO2000066223A1 *May 2, 2000Nov 9, 2000Franz KrispelRotating stereotactic treatment system
WO2002002188A1 *Jul 5, 2000Jan 10, 2002Muradin Abubekirovich KumakhovRoentgen device for localization and radiation therapy of cancellation cancers
WO2008043196A1 *Sep 22, 2006Apr 17, 2008Wang QiaoshengAn intensity modulated grating system of compensating disintegration type honeycomb array and using method thereof
Classifications
U.S. Classification378/65, 378/68
International ClassificationA61N5/10
Cooperative ClassificationA61N5/1084
European ClassificationA61N5/10J10
Legal Events
DateCodeEventDescription
Jul 10, 2001FPExpired due to failure to pay maintenance fee
Effective date: 20010506
May 6, 2001LAPSLapse for failure to pay maintenance fees
Nov 28, 2000REMIMaintenance fee reminder mailed
Apr 14, 1995ASAssignment
Owner name: ATEA, SOCIETE ATLANTIQUE DE TECHNIQUES AVANCEES, F
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:KOPECKY, BERNARD;REEL/FRAME:007430/0795
Effective date: 19950221